OS Therapies Incorporated (OSTX)

OS Therapies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-7.36	-7.79	-6.25	-7.42	-6.03
Depreciation & Amortization	0	0	0	0	0
Other Amortization	1.64	2.65	1.15	2.07	0.27
Other Operating Activities	-	0.12	0.36	0.37	2.38
Change in Accounts Payable	-0.71	1.35	0.22	0.86	0
Change in Other Net Operating Assets	0.65	0.67	0.73	-0.28	0.96
Operating Cash Flow	-5.78	-3.01	-3.79	-4.4	-2.41
Capital Expenditures	0	-	-	-0.01	-0
Other Investing Activities	-	0	0.23	0.21	0.16
Investing Cash Flow	0	0	0.23	0.2	0.16
Long-Term Debt Issued	-	3.16	3.82	2.95	3.6
Long-Term Debt Repaid	-	-	-	-	-0.12
Net Debt Issued (Repaid)	2.57	3.16	3.82	2.95	3.48
Issuance of Common Stock	5.23	-	-	-	0
Other Financing Activities	-0.18	-0.28	-0.17	0.1	-
Financing Cash Flow	7.62	2.87	3.65	3.05	3.48
Net Cash Flow	1.84	-0.13	0.09	-1.15	1.22
Free Cash Flow	-5.78	-3.01	-3.79	-4.41	-2.42
Free Cash Flow Per Share	-0.59	-0.28	-0.38	-0.44	-0.29
Cash Interest Paid	-	-	-	0.01	0.01
Levered Free Cash Flow	-9.26	1.31	-0.2	-0.97	-
Unlevered Free Cash Flow	-9.43	0.82	-0.22	-1.43	-
Change in Net Working Capital	6.31	-3.53	-2.56	-1.6	-

Source: S&P Capital IQ. Standard template. Financial Sources.